Free Trial

U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Silvercrest Asset Management Group LLC

U.S. Physical Therapy logo with Medical background

Silvercrest Asset Management Group LLC boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 189,115 shares of the company's stock after acquiring an additional 37,523 shares during the quarter. Silvercrest Asset Management Group LLC owned 1.25% of U.S. Physical Therapy worth $16,776,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC increased its position in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after purchasing an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in U.S. Physical Therapy during the fourth quarter valued at approximately $39,000. Venturi Wealth Management LLC increased its holdings in U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after buying an additional 704 shares during the last quarter. Lazard Asset Management LLC bought a new position in U.S. Physical Therapy in the fourth quarter worth approximately $84,000. Finally, Pacer Advisors Inc. purchased a new position in shares of U.S. Physical Therapy during the 4th quarter worth $113,000.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Barrington Research decreased their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Finally, StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, U.S. Physical Therapy currently has a consensus rating of "Moderate Buy" and a consensus target price of $109.00.

Read Our Latest Stock Report on USPH

U.S. Physical Therapy Stock Down 0.5%

Shares of U.S. Physical Therapy stock traded down $0.38 during trading on Tuesday, reaching $79.33. The company's stock had a trading volume of 60,173 shares, compared to its average volume of 110,870. The company has a market cap of $1.21 billion, a price-to-earnings ratio of 84.39, a P/E/G ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $106.06. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a 50-day simple moving average of $71.89 and a two-hundred day simple moving average of $83.56.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. During the same quarter in the prior year, the firm earned $0.51 earnings per share. U.S. Physical Therapy's revenue for the quarter was up 18.0% on a year-over-year basis. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 23rd will be given a dividend of $0.45 per share. The ex-dividend date is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.27%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This represents a 19.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines